CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
109 hedge funds and large institutions have $1.9B invested in China Biologic Products Holdings, Inc. in 2015 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
32% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 28
16% more call options, than puts
Call options by funds: $18.8M | Put options by funds: $16.3M
Holders
109
Holding in Top 10
6
Calls
$18.8M
Puts
$16.3M
Top Buyers
| 1 | +$117M | |
| 2 | +$66.4M | |
| 3 | +$27.2M | |
| 4 |
Bank of New York Mellon
New York
|
+$21.8M |
| 5 |
KM
Kylin Management
New York
|
+$21.7M |
Top Sellers
| 1 | -$305M | |
| 2 | -$8.34M | |
| 3 | -$3.94M | |
| 4 |
Renaissance Technologies
New York
|
-$3.37M |
| 5 |
SIM
Spark Investment Management
New York
|
-$2.93M |